- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Balchem Corporation(BCPC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BCPC
09/25/2026: BCPC (1-star) is currently NOT-A-BUY. Pass it for now.
Balchem Corporation is a specialized company operating in the nutritional and performance ingredient markets. The company is known for its proprietary encapsulation and chelation technologies, which give it a leading position in niche areas like human and animal health. Its primary investment story centers on sustained growth through acquisitions and a focus on high-margin segments in the food and medical industries. However, investors should monitor risks regarding input cost volatility, high valuation multiples, and the successful execution of M&A strategies. Balchem is generally suited for growth-oriented investors seeking long-term exposure to health and wellness trends, while dividend-focused investors may find the yield modest.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Balchem consistently grows via its niche specialty ingredients and strategic M&A. |
| Momentum investor | Strong fit while signal remains positive | The stock often trends well during periods of sector-specific expansion. |
| Value investor | Mixed fit | The company often trades at a premium valuation due to its quality and growth profile. |
| Dividend investor | Mixed fit | It pays a modest dividend but is primarily a capital appreciation play. |
| Low-risk investor | Medium | Exposure to industrial and agricultural markets introduces some inherent volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock price can fluctuate based on broader market sentiment and input cost inflation. |
| Valuation risk | Medium / high | High P/E multiples require sustained earnings growth to justify current share prices. |
| Competition risk (specialty ingredients) | Medium | Larger players like IFF or BASF can compete on scale and pricing in certain markets. |
| Business quality | Strong | The company's proprietary technology and niche dominance indicate high franchise quality. |
| Dividend income | Low | The dividend yield is not the primary driver of total returns for this stock. |
| Execution risk | Medium | Successfully integrating acquisitions is crucial to maintaining growth momentum. |
Price Behavior

Flat / Range-Bound
The stock price has been trading within a narrow range with minimal directional movement.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -21.37% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.35B USD | Price to earnings Ratio 32.98 | 1Y Target Price 209.25 |
Price to earnings Ratio 32.98 | 1Y Target Price 209.25 | ||
Volume (30-day avg) 193.2K shares | Beta 0.81 | 52 Weeks Range 138.32 - 183.90 | Updated Date 09/27/2026 |
52 Weeks Range 138.32 - 183.90 | Updated Date 09/27/2026 | ||
Dividends yield (FY) 0.57% | Basic EPS (TTM) 5.09 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Human Nutrition & Health | Chelated minerals, choline, and encapsulated functional ingredients for food and supplements. | This is a high-margin segment benefiting from global health and wellness trends. |
| Animal Nutrition & Health | Rumen-protected nutrients and performance additives for livestock. | This segment provides stability through steady demand for agricultural productivity products. |
| Specialty Products | Performance gases like ethylene oxide for medical sterilization. | This acts as a steady, infrastructure-linked business supporting the healthcare supply chain. |
| Geography (Global) | Manufacturing and sales across North America, Europe, and emerging markets. | Global diversification helps mitigate local economic slowdowns. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 32.98 | Forward PE 29.33 | Enterprise Value 5.47B | Price to Sales(TTM) 4.93 |
Enterprise Value 5.47B | Price to Sales(TTM) 4.93 | ||
Enterprise Value to Revenue 5.04 | Enterprise Value to EBITDA 20.34 | Shares Outstanding 31.88M | Shares Floating 31.69M |
Shares Outstanding 31.88M | Shares Floating 31.69M | ||
Percent Insiders 0.49 | Percent Institutions 93.81 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Balchem Corporation
Exchange NASDAQ | Headquarters Montvale, NJ, United States | ||
IPO Launch date 1986-06-03 | CEO, President & Chairman Mr. Theodore Lee Harris | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 1379 | Website https://www.balchem.com |
Full time employees 1379 | Website https://www.balchem.com | ||
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

